Search Results
Test Catalog
C6FX - Overview: C6 Complement, Functional, Serum
Diagnosis of C6 deficiency Investigation of a patient with an undetectable total complement level
C5FX - Overview: C5 Complement, Functional, Serum
Diagnosis of C5 deficiency Investigation of a patient with an undetectable total complement level
CD273 - Overview: CD273 (PD-L2) Immunostain, Technical Component Only
Differentiation of primary mediastinal large B-cell lymphoma from diffuse large B cell-lymphoma
CEAPC - Overview: Carcinoembryonic Antigen (CEA), Pancreatic Cyst Fluid
When used in conjunction with imaging studies, cytology, and other pancreatic cyst fluid tumor markers: -Distinguishing between mucinous and nonmucinous pancreatic cysts -Determining the likely type of malignant pancreatic cyst
CA - Overview: Calcium, Total, Serum
Diagnosis and monitoring of a wide range of disorders including diseases of bone, kidney, parathyroid gland, or gastrointestinal tract
CLOM - Overview: Clomipramine, Serum
Determining whether a poor therapeutic response is attributable to noncompliance Monitoring serum concentration of clomipramine and norclomipramine to assist in optimizing the administered dose
EMICZ - Overview: Emicizumab, Modified One Stage Assay Factor VIII, Plasma
Monitoring compliance or potential development of an antidrug antibody This assay is not indicated for monitoring factor VIII infusions or for making a diagnosis of hemophilia.
EEPC - Overview: Eastern Equine Encephalitis Antibody Panel, IgG and IgM, Spinal Fluid
Aiding in the diagnosis of Eastern equine encephalitis using spinal fluid specimens
ERG - Overview: ERG Immunostain, Technical Component Only
Identification of erythroblast transformation specific (ETS)-related gene (ERG) protein expression
FACR8 - Overview: Factor 8 Related Antigen Immunostain, Technical Component Only
Marker of endothelial cell lineage
LEFLU - Overview: Leflunomide Metabolite (Teriflunomide), Serum
Therapeutic monitoring of patients actively taking leflunomide Assessment of elimination in patients requiring enhanced elimination of the drug
LAMO - Overview: Lamotrigine, Serum
Monitoring serum concentration of lamotrigine Assessing compliance Adjusting lamotrigine dose in patients receiving other anticonvulsant drugs that interact pharmacokinetically with lamotrigine
FMNPP - Overview: Motor Neuropathy Panel
Motor Neuropathy Panel
LPSBF - Overview: Lipase, Body Fluid
Determining whether pancreatic inflammation or pancreatic fistula may be contributing to a pathological accumulation of fluid
KRT34 - Overview: Keratin (34BE12) Immunostain, Technical Component Only
Identification of cells expressing high-molecular-weight cytokeratin
MCRPL - Overview: Macroprolactin, Serum
Determining biologically active levels of prolactin, in asymptomatic patients with elevated prolactin levels Ruling out the presence of macroprolactin
MYGLU - Overview: Myoglobin, Random, Urine
Confirming the presence of a myopathy
Characterizing neoplasms of cytotoxic T cells or natural killer cells
TIBC - Overview: Total Iron Binding Capacity, Serum
Screening for chronic iron overload diseases, particularly hereditary hemochromatosis
SV40 - Overview: SV40 Immunostain, Technical Component Only
Identifying BK or JC polyomavirus
TRYPN - Overview: Trypsin Immunostain, Technical Component Only
Identifying cells with acinar differentiation in the pancreas
TDT - Overview: Terminal Deoxynucleotidyl Transferase (TdT) Immunostain, Technical Component Only
Classification of leukemias or lymphomas
TFE3I - Overview: Transcription Factor E3 (TFE3) Immunostain, Technical Component Only
Assessment of transcription factor E3 expression
TTFSP - Overview: Thyroid Transcription Factor (SPT24) Immunostain, Technical Component Only
Part of a panel of immunostains to identify the primary site for carcinomas of unknown origin
FRT4 - Overview: T4 (Thyroxine), Free, Serum
Evaluating suspected thyroid function disorders using free thyroxine measured together with thyroid-stimulating hormone
SALL4 - Overview: SALL4 Immunostain, Technical Component Only
Aids in the identification of germ cell tumors
TCL1A - Overview: T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Immunostain, Technical Component Only
Identification of T-cell leukemia and lymphoma protein overexpression in neoplasms
TIA1 - Overview: T-Cell Intracellular Antigen 1 (TIA-1) Immunostain, Technical Component Only
Characterizing neoplasms of cytotoxic T cells or natural killer cells
CYTH1 - Overview: T-Helper Cell Type 1 Cytokine Panel, Plasma
Assessment of plasma cytokine levels to understand the etiology of autoimmune and proinflammatory conditions when used in conjunction with clinical information and other laboratory testing
TACPK - Overview: Tacrolimus, Peak, Blood
Assessment of postdosing (peak) blood tacrolimus concentrations
Interpretation for the evaluation of stiff-person spectrum disorders, including the classical or focal forms, such as stiff-limb or stiff-trunk, and progressive encephalomyelitis with rigidity and myoclonus, using spinal fluid specimens
WNVSI - Overview: West Nile Serum Interpretation
Interpretation of testing for a laboratory diagnosis of infection with West Nile virus
WT1I - Overview: Wilms Tumor (WT-1) Immunostain, Technical Component Only
Aiding in the identification of Wilms tumor
B6PA - Overview: Pyridoxic Acid, Plasma
Determining the concentration of pyridoxic acid in the assessment of vitamin B6 status
APTTP - Overview: Activated Partial Thromboplastin Time, Plasma
Monitoring heparin therapy (unfractionated heparin) Screening for certain coagulation factor deficiencies Detection of coagulation inhibitors such as lupus anticoagulant, specific factor inhibitors, and nonspecific inhibitors
VITK1 - Overview: Vitamin K1, Serum
Assessment of circulating vitamin K1 concentration.
INS - Overview: Insulin, Serum
Diagnosing insulinoma, when used in conjunction with proinsulin and C-peptide measurements Management of diabetes mellitus
FENTS - Overview: Fentanyl, Serum
Monitoring fentanyl therapy
FENTU - Overview: Fentanyl with Metabolite Confirmation, Random, Urine
Detection and confirmation of illicit drug use involving fentanyl
HAD - Overview: Huntington Disease, Molecular Analysis, Varies
Molecular confirmation of clinically suspected cases of Huntington disease (HD) Presymptomatic testing for individuals with a family history of HD and a documented expansion in the HTT gene
TRIG1 - Overview: Triglycerides, Serum
Managing atherosclerotic cardiovascular disease risk
OSM24 - Overview: Osmolality, 24 Hour, Urine
Assessing the concentrating and diluting ability of the kidney using a 24-hour urine collection
TRYPP - Overview: Tryptophan, Plasma
Investigating inadequate tryptophan intake and monitoring dietary treatment
PACP - Overview: Prostatic Acid Phosphatase, Serum
Aiding in predicting recurrence after radical prostatectomy for clinically localized prostate cancer Following response to androgen ablation therapy, when used in conjunction with prostate-specific antigen
ALP - Overview: Alkaline Phosphatase, Serum
Diagnosing and monitoring treatment of liver, bone, intestinal, and parathyroid diseases
CDCOM - Overview: Celiac Disease Comprehensive Cascade, Serum and Whole Blood
Evaluating patients suspected of having celiac disease, including patients with compatible symptoms, patients with atypical symptoms, and individuals at increased risk (family history, previous diagnosis with associated...
GNPFD - Overview: Platelet Function Defect Gene Panel, Next-Generation Sequencing, Varies
Diagnosing hereditary platelet function defect disorders for patients who have a distinct platelet function defect pattern, such as Bernard-Soulier syndrome, revealed by laboratory phenotypic testing Confirming a hereditary platelet...
ALDU - Overview: Aldosterone, 24 Hour, Urine
Investigating primary aldosteronism (eg, adrenal adenoma/carcinoma and adrenal cortical hyperplasia) and secondary aldosteronism (renovascular disease, salt depletion, potassium loading, cardiac failure with ascites, pregnancy, Bartter...
BMIYC - Overview: Borrelia miyamotoi Detection PCR, Spinal Fluid
Aids in the diagnosis of Borrelia miyamotoi infection in conjunction with clinical findings This test is not useful for detecting the Borrelia species that cause Lyme disease.
RALB1 - Overview: Albumin, Random, Urine
Assessing the potential for early onset of nephropathy in diabetic patients using random urine specimens
Site Search
Information: Interpreting Laboratory Tests to Determine New vs. Residual Use of Marijuana - Insights
In this month's "Hot Topic," Paul Jannetto, Ph.D., identifies how to determine new vs. residual use of marijuana in a patient, and teaches how to calculate the carboxy-tetrahydrocannabinol (carboxy-THC)...
Laboratory and Pathology Research Roundup: March 12 - Insights
known. We performed laser microdissection (LCM) of glomeruli followed by mass spectrometry (MS) in 12 cases each of DDD, C3GN, and pretransplant kidney control biopsies....
COVID-19: At-home sample collection vs. at-home testing - Insights
The concept of at-home testing for COVID-19 sounds straightforward. But there's nuance to it that's important to understand. Right now, an at-home test for COVID-19 is not available, although there may be one coming soon. But in some areas,...
Transfusion Toons: A1 vs. A2 - Insights
Justin Kreuter, M.D., Clinical Pathologist and Medical Director of the Mayo Clinic Blood Donor Center in Rochester, Minnesota, and Theresa Malin, an Education Specialist in Transfusion Medicine at Mayo Clinic, have launched “Transfusion...
Clinic Laboratory and Pathology Research Roundup: Nov. 12 - Insights
This week’s Research Roundup highlights a mechanism for preventing asymmetric histone segregation onto replicating DNA strands.